Back

Comparative genomics and integrated system biology approach unveiled undirected phylogeny patterns, mutational hot spots, functional patterns and molecule repurposing for monkey pox virus

GUPTA, V.; Singhvi, N.; Kaur, J.; Tyagi, I.; Talwar, C.; Mondal, K.; Ahmad, N.; Sharma, G.; Mahanta, U.

2022-12-27 genomics
10.1101/2022.12.21.521441 bioRxiv
Show abstract

Monkeypox is a viral zoonosis with symptoms that are reminiscent to those experienced in previous smallpox cases. GSAID databases (Global Initiative on Sharing Avian Influenza Data) was used to assess 630 genomes of MPXV. Six primary clades were inferred from the phylogenetic study, coupled with a lesser percentage in radiating clades. Individual clades that make up various nationalities may have formed as a result of a particular SNP hotspot type, which may have mutated in a particular population type. The most significant mutation, based on a mutational hotspot analysis, was found at G3729A and G5143A. The gene ORF138, which encodes the Ankyrin repeat (ANK) protein, was found to have the most mutations. This protein is known to mediate molecular recognition via protein-protein interactions. It was shown that 243 host proteins interacted with 10 monkeypox proteins identified as the hub proteins E3, SPI2, C5, K7, E8, G6, N2, B14, CRMB, and A41 through 262 direct connections. The interaction with chemokine system-related proteins provides further evidence that the human protein is being suppressed by the monkey pox virus in order to facilitate its survival against innate immunity. A few FDA-approved molecules were likely used as possible inhibitors after being researched for blocking F13, a significant envelope protein on the membrane of extracellular versions of virus. A total of 2500 putative ligands were docked individually with the F13 protein. The F13 protein and these molecules interaction may help prevent the monkey pox virus from spreading. As a result, after being confirmed by experiments, these putative inhibitors might have an impact on the activity of these proteins and be utilised in monkeypox treatments.

Matching journals

The top 10 journals account for 50% of the predicted probability mass.

1
Virus Research
36 papers in training set
Top 0.1%
10.5%
2
Gene Reports
13 papers in training set
Top 0.1%
6.9%
3
Archives of Virology
14 papers in training set
Top 0.1%
4.9%
4
Frontiers in Genetics
197 papers in training set
Top 1%
4.9%
5
Heliyon
146 papers in training set
Top 0.1%
4.9%
6
Viruses
318 papers in training set
Top 1%
4.9%
7
Frontiers in Microbiology
375 papers in training set
Top 2%
4.3%
8
PLOS ONE
4510 papers in training set
Top 36%
4.0%
9
Journal of Medical Virology
137 papers in training set
Top 0.7%
4.0%
10
Journal of Virology
456 papers in training set
Top 1%
4.0%
50% of probability mass above
11
International Journal of Biological Macromolecules
65 papers in training set
Top 0.6%
3.6%
12
Genomics
60 papers in training set
Top 0.4%
2.9%
13
Scientific Reports
3102 papers in training set
Top 47%
2.4%
14
Archives of Clinical and Biomedical Research
28 papers in training set
Top 0.4%
2.1%
15
Emerging Microbes & Infections
74 papers in training set
Top 0.7%
1.9%
16
PLOS Pathogens
721 papers in training set
Top 6%
1.7%
17
Computers in Biology and Medicine
120 papers in training set
Top 2%
1.7%
18
BMC Genomics
328 papers in training set
Top 3%
1.5%
19
F1000Research
79 papers in training set
Top 2%
1.3%
20
Journal of General Virology
46 papers in training set
Top 0.5%
1.2%
21
Infection, Genetics and Evolution
43 papers in training set
Top 0.6%
1.2%
22
Genes
126 papers in training set
Top 2%
1.2%
23
Frontiers in Immunology
586 papers in training set
Top 6%
1.0%
24
Pathogens
53 papers in training set
Top 1%
1.0%
25
Antiviral Research
49 papers in training set
Top 0.3%
0.9%
26
mSystems
361 papers in training set
Top 6%
0.9%
27
Microbiology Spectrum
435 papers in training set
Top 4%
0.9%
28
Frontiers in Public Health
140 papers in training set
Top 7%
0.9%
29
Frontiers in Cellular and Infection Microbiology
98 papers in training set
Top 5%
0.8%
30
Journal of Clinical Virology
62 papers in training set
Top 0.8%
0.8%